It is now clear that over recent generations there has been a distinct rise in Type 1 diabetes. You may never have consi…
Science
DreaMed Uses AI to Improve Diabetes Management
With the recent proliferation of advanced diabetes technology, people with Type 1 diabetes now enjoy an unprecedented ab…
Did a Common Cholesterol Drug Reverse One Teen’s Type 1 Diabetes?
Did fenofibrate – a common cholesterol drug – reverse one 19-year old woman’s newly diagnosed Type 1 diabetes?
This is t…
Some Hope for Your Beta Cells
We all know that in Type 1 diabetes, the pancreas’ beta cells cease to function. But are they eliminated? Do they die? O…
Type 1 Diabetes Up 30% Since 2017, According to CDC Report
Aaron J. Kowalski, Ph.D., President and CEO of JDRF has issued a statement based on two new reports issued by the Center…
Is Type 1 Diabetes Much More Common than We Think?
Is Type 1 diabetes dramatically more common than is widely understood? That’s the contention of Dr. David Leslie, Profes…
Can Diabetes Drug Trials be Trusted?
Researchers Raise Doubt Over Major Diabetes Drug Trials
The FDA requires pharmaceutical companies developing diabetes dr…
JDRF’s Top 10 Diabetes Advances of 2019
JDRF is calling 2019, “a banner year for Type 1 diabetes breakthroughs.” Check out their list below to find …
New Artificial Pancreas: FDA Authorizes Tandem Diabetes Care Control-IQ Technology
The U.S. FDA has authorized marketing of the Tandem Diabetes Care Control-IQ Technology, an interoperable automated glyc…
JDRF Launches Northern California Center of Excellence to Develop Cures for Type 1 Diabetes
JDRF has announced the launch of the JDRF Northern California Center of Excellence, to accelerate high-impact research a…
